Chronic Complications of Type 2 Diabetes: Prevalence, Prevention, and Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".
Deadline for manuscript submissions: 25 January 2025 | Viewed by 43
Special Issue Editor
Interests: chronic complications of diabetes; prevention of diabetes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The prevalence of type 2 diabetes is increasing rapidly among younger age groups. Estimates suggest that people with diabetes die, on average, 6 years earlier than people without diabetes. Chronic complications of type 2 diabetes are due to myriad disorders and numerous metabolic pathways that are responsible for most of the morbidity and mortality associated with the disease. These are, in general, divided into micro- and macrovascular complications. Microvascular complications in diabetes result from the impairment of small blood arteries, leading to a large increase in morbidity. Retinopathy, nephropathy, and neuropathy are prevalent microvascular consequences. The development of microvascular problems in diabetes is closely associated with the combined impact of long-term high blood sugar levels, abnormal lipid levels, and high blood pressure. The major forms of macrovascular disease are coronary heart disease, stroke, and peripheral vascular disease, which share both an atherosclerotic background and several common risk factors. The relationship between diabetes and cardiovascular illness is complex, encompassing dyslipidemia, hypertension, and a proinflammatory state associated with diabetes cardiovascular events, which remains the major cause of death for those with diabetes.
We call on clinicians, researchers, and healthcare professionals to contribute their expertise and findings to this Special Issue. By consolidating knowledge and fostering clinical innovation, we aim to improve the prevention, diagnosis, and treatment of chronic complications in type 2 diabetes, ultimately enhancing patient outcomes and quality of life.
Dr. Ilias Migdalis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pathogenesis of diabetic complications
- epidemiology of diabetic complications
- diabetic retinopathy
- diabetic chronic kidney disease
- diabetes neuropathies
- coronary heart disease
- peripheral vascular disease
- hypertension and dyslipidemia in diabetes
